Rubrik: Technik
(Treffer aus pharmind, Nr. 08, Seite 770 (2024))
Judd S
Evolution of CCS and Sustainability / In Biopharmaceutical Manufacturing · Judd S · Arcadis
Process Closure ATMP Sustainability Biopharmaceutical Manufacturing Facility Design The requirements for modern biotech facilities are changing. This is driven by the evolving landscape of the different ATMP production modalities and the need to get these remarkable therapies to market in a timely, but safety manner. The ATMP field includes Cell and Gene Therapy (C>) which is a broad arena covering a range of different modalities. Only a relatively small number of these therapies have been approved for market compared to the number that are either in development or in various stages of clinical trials [ 1 ]. It is expected that ...